Heart Conditions clinical trials at UC Davis

3 research studies open to eligible people

Showing trials for

  • Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18 years and up

    Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.

    Sacramento, California and other locations

  • Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

    “Learn more about the REACT-AF Study!”

    open to eligible people ages 22-85

    REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in participants with a history of paroxysmal or persistent Atrial Fibrillation (AF) and low-to-moderate stroke risk.

    Sacramento, California and other locations

  • Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

    “Volunteer for research and contribute to discoveries that may improve heart health for you, your family, and your community!”

    open to eligible people ages 18 years and up

    The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially available LAAC devices in participants with non-valvular atrial fibrillation (NVAF) to reduce the risk of stroke (blocked blood vessel or bleeding in brain) and systemic embolism (blockage in a blood vessel harming vital organs).

    Rancho Cordova, California and other locations

Our lead scientists for Heart Conditions research studies include .

Last updated: